microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 1039-1048

  Chen, Wei Chang ^a   Lin, Mao Song ^b   Ye, Yu Lan ^a   Gao, Heng Jun ^c,d   Song, Zhen Yun ^d   Shen, Xiao Ying ^d  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b TAIZHOU PEOPLE S HOSPITAL   (China)

^c TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^d National Engineering Center for Biochip Design and Engineering   (China)

Author keywords

Celecoxib; Colorectal cancer; Microarray; microRNA; RT PCR

Indexed keywords

CELECOXIB; MICRORNA; MICRORNA 133B; MICRORNA 139 3P; MICRORNA 142 3P; MICRORNA 142 5P; MICRORNA 26A 1; MICRORNA 552; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; DRUG TARGETING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84859578776     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.531     Document Type: Article

References (39)

1. Lee HK, Choi YS, Park YA and Jeong S: Modulation of oncogenic transcription and alternative splicing by β-catenin and an RNA aptamer in colon cancer cells. Cancer Res 66: 10560-10566, 2006.
2. Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, JassJR, HopperJL, Diep A, Bapat B, Salem M, Seminara D, Haile R for the Colon Cancer Family Registry: Conversion analysis formutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 293: 799-809, 2005.
3. Hung KE and Chung DC: New insights into the molecular pathogenesis of colorectal cancer. Drug Discov Today Dis Mech3: 439-445, 2006.
4. Bartel DP: MicroRNAs: genomic, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N and Shiekhattar R: The microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240, 2004.
6. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
7. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, etal: Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA99: 15524-15529, 2002.
8. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T and Takahashi T: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
9. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce CM: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908, 2007.
10. Nagel R, Le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R: Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68: 5795-5802, 2008.
11. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K and Mori M: Over-and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075, 2009.
12. Valeri N, Croce CM and Fabbri M: Pathogenetic and clinical relevance of microRNAs in colorectal cancer. Cancer Genomics Proteomics 6: 195-204, 2009.
13. Toyoshima T, Kamijo R, Takizawa K, Sumitani K, Ito D and Nagumo M: Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21. Br J Cancer 6: 1150-1156, 2002.
14. 2+-ATPases: a plausible link with its antitumor effect and cardiovascular risks. Biochem J 366: 831-837, 2002.
15. Zhu J, Huang JW, Tseng PH, Yang YT, Fowble J, Shiau CW, Shaw Y, Kulp SK and Chen CS: From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res 64: 4309-4318, 2004.
16. Iorio MV, Manuela F, Liu CG, Angelo V, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M and Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res65: 7065-7070, 2005.
17. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135: 255-260, 2008.
18. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microNRA sequences, target and gene nomenclature. Nucleic Acids Res 34: 140-144, 2006.
19. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003.
20. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DLW, Au GKH, etal: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
21. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Bergemann TL, Gupta M, O'Sullivan MG, Matise I, Dupuy AJ, etal: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401-406, 2009.
22. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, etal: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469, 2008.
23. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Pec kD, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, etal: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
24. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M and Garcia-Foncillas J: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
25. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737-2743, 2009.
26. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ, Kruhøffer M, Laurberg S, etal: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6124, 2008.
27. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
28. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, etal: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2005.
29. He L, Thomson JM, Hemann MT, Hernando-Mong E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, HannonGJ and Hammond SM: A microRNA polyistron as a potential human oncogene. Nature 435: 828-833, 2005.
30. Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, You J and Hu XQ: Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep 21: 673-679, 2009.
31. Calin GA, Sevignani C, Ferrai JG, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M and Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
32. Shen J, Ambrosone CB and Zhao H: Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer 124: 1178-1182, 2009.
33. Patnaik SK, Kannisto E, Knudsen S and Yendamuri S: Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45, 2010.
34. Zanette DL, Rivadavia F, Jacoby S, Barbuzano FG, Proto-Siqueira R, Silva WA Jr, Falcao RP and Zago MA: MiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Bio Res 40: 1435-1440, 2007.
35. Bussing I, Slack FJ and Grosshans H: Let-7 microRNAs in development stem cells and cancer. Trends Mol Med 14: 400-409, 2008.
36. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
37. Lee YS and Dutta A: The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030, 2007.
38. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP and Krueger LJ: MicroRNA let-7a down regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67: 9762-9770, 2007.
39. Meng F, Henson R, Iinuma M, Smith H, Ueno Y and Patel T: The microRNA let-7a modulates interleukin-6 dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem 282: 8256-8264, 2007.